Nektar Therapeutics


Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.

Industries

Employees

501-1,000

Links


Org chart

Howard Robin
President & CEO
Collapse
Jonathan Zalevsky
Chief Scientific Officer
Mark A. Wilson
SVP, General Counsel
Jennifer Ruddock
Senior Vice President & Chief Business Officer
Angeline Tan
Vice President Of R&d QA
Ken Franke
Senior Vice President, Biologics Development And Manufacturing
Jill Thomsen
SVP And Chief Financial Officer
Jeanette G. (Jenny)
Director Clinical Operations
Connie Louie-Tse
Executive Director
Wanda Allen
Data Mgmt Spec III
Lydia Falk
Executive Director
Sohail Chaudhry
Vice President, Clinical Development
Dorian Rinella
Sr V P Human Resources

Board & advisors